Julien Fleurence Selected Research

O-acetyl-GD2 ganglioside

1/2017

Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julien Fleurence Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 01/2012
2	Glioma (Gliomas) 01/2020 - 07/2016
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 07/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Neuralgia (Stump Neuralgia) 01/2017

Drug/Important Bio-Agent (IBA)

5	Monoclonal AntibodiesIBA 01/2020 - 01/2012
2	GD2 gangliosideIBA 01/2020 - 07/2016
2	AntigensIBA 01/2017 - 07/2016
2	globotriaosylceramide (globotriosylceramide)IBA 04/2013 - 01/2012
1	NestinIBA 01/2020
1	interleukin-21 (interleukin 21)IBA 01/2020
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	Interleukin-15 (Interleukin 15)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	GlycolipidsIBA 01/2017
1	dinutuximabIBA 01/2017
1	GangliosidesIBA 01/2017
1	O-acetyl-GD2 gangliosideIBA 01/2017

Therapy/Procedure

3	Immunotherapy 01/2020 - 01/2012
3	Therapeutics 01/2020 - 01/2019